Harjutsalo Valma, Sjöberg Lena, Tuomilehto Jaakko
Diabetes Unit, Department of Health Promotion and Chronic Disease Prevention, National Public Health Institute, Helsinki, Finland.
Lancet. 2008 May 24;371(9626):1777-82. doi: 10.1016/S0140-6736(08)60765-5.
Finland has the highest incidence of type 1 diabetes worldwide, reaching 40 per 100,000 people per year in the 1990s. Our aim was to assess the temporal trend in type 1 diabetes incidence since 2000 in Finnish children aged younger than 15 years and to predict the number of cases of type 1 diabetes in the future.
Children with newly diagnosed type 1 diabetes in Finland who were listed on the National Public Health Institute diabetes register, Central Drug Register, and Hospital Discharge Register in 1980-2005 were included in a cohort study. We excluded patients with type 2 diabetes and diabetes occurring secondary to other conditions, such as steroid use, Down's syndrome, and congenital malformations of pancreas.
10,737 children-5816 boys and 4921 girls-were diagnosed with type 1 diabetes before 15 years of age during 1980-2005. The average age-standardised incidence was 42.9 per 100,000 per year (95% CI 42.6-44.3) during this period, increasing from 31.4 per 100,000 per year in 1980 to 64.2 per 100,000 per year in 2005. The age-specific rates per 100,000 per year were 31.0, 50.5, and 50.6 at ages 0-4 years, 5-9 years, and 10-14-years, respectively. We noted a significant non-linear component to the time trend (p<0.0003). In children aged 0-4 years, the increase was largest, at 4.7% more affected every year. The overall boy-to-girl ratio of incidence was 1.1; at the age of 13 years, it was 1.7 (1.4-2.0). The predicted cumulative number of new cases with type 1 diabetes before 15 years of age between 2006 and 2020 was about 10 800.
The incidence of type 1 diabetes in Finnish children is increasing even faster than before. The number of new cases diagnosed at or before 14 years of age will double in the next 15 years and the age of onset will be younger (0-4 years).
芬兰是全球1型糖尿病发病率最高的国家,在20世纪90年代达到每年每10万人中有40例。我们的目的是评估2000年以来15岁以下芬兰儿童1型糖尿病发病率的时间趋势,并预测未来1型糖尿病的病例数。
纳入1980 - 2005年在芬兰国家公共卫生研究所糖尿病登记册、中央药物登记册和医院出院登记册上登记的新诊断为1型糖尿病的儿童进行队列研究。我们排除了2型糖尿病患者以及继发于其他疾病(如使用类固醇、唐氏综合征和胰腺先天性畸形)的糖尿病患者。
1980 - 2005年期间,10737名儿童——5816名男孩和4921名女孩——在15岁之前被诊断为1型糖尿病。在此期间,年龄标准化发病率平均为每年每10万人42.9例(95%置信区间42.6 - 44.3),从1980年的每年每10万人31.4例增至2005年的每年每10万人64.2例。0 - 4岁、5 - 9岁和10 - 14岁儿童每年每10万人的发病率分别为31.0例、50.5例和50.6例。我们注意到时间趋势存在显著的非线性成分(p<0.0003)。在0 - 4岁儿童中,发病率增长最大,每年增加4.7%。总体发病率的男女性别比为1.1;在13岁时,性别比为1.7(1.4 - 2.0)。预计2006年至2020年期间15岁之前新诊断的1型糖尿病累积病例数约为10800例。
芬兰儿童1型糖尿病的发病率增长甚至比以前更快。在未来15年里,14岁及以下诊断出的新病例数将翻倍,且发病年龄将更小(0 - 4岁)。